Dr. Hong Weilian, Dean of Junyao Runying Research Institute, confirmed his attendance to demystify the "last mile" of weight management with AKK bacteria!
In recent years, with the continued in-depth research on the gut microbiome,Probiotic Function DevelopmentHas expanded from traditional digestive health to metabolic regulation, immune support, and neuropsychiatric domains. Among these, Akkermansia muciniphila (AKK) is considered one of the most representative next-generation probiotics due to its strong association with obesity, type 2 diabetes, and other metabolic syndrome conditions.
However, the intense competition in the current market is undeniable. How can we truly break through?From strain screening and evidence-based research to industrial applicationThe "last mile" remains a tough challenge for the industry. In weight management—a universal consumer need—concept-driven products lacking solid data continue to flood the market. The market has high expectations for the next generation of innovative solutions backed by robust evidence.
Against this backdrop,2026 BIO-TECH China 2025 will be held in Shanghai from 8 to 28.At the exhibition, we will invite2000+Attendee,150+Speaker,50+Premium exhibitors, featuring "Exhibitions - Products - Conferences - PartnershipsFour core modules focused on "fundamental research breakthroughs + cross-domain industrial implementation," providing comprehensive coverage.Medical aesthetics, bio-based materials, green chemicals, food, agriculture, AI-enabledSix core domains driving deep collaboration among top research experts, industry leaders, innovative SMEs, investment firms, and upstream/downstream supply chains to create the premier biomanufacturing ecosystem showcase.
This conference has specially invited the Dean of Junyao Runying Research Institute.Dr. Hong WeilianAttend the exhibition, share cutting-edge insights, and engage in efficient dialogue with industry peers. Stay tuned!
Dr. Hong WeilianGraduated from the Dental Institute at King's College London with a Ph.D. in Microbiology, Dr. Hong currently serves as President of Junyao Runying Research Institute, Senior Engineer, and Doctoral Supervisor at the Department of Nutrition and Health, China Agricultural University. He is an Executive Member of the International Dairy Federation (IDF) for Microbial Analysis and a member of the Chinese Nutrition Society. Previously, he led probiotic business operations at Yili Group and possesses over 20 years of research experience in the probiotics and nutrition health fields.
Junyao Runying Research Institute belongs to Junyao Runying Biotechnology (Shanghai) Co., Ltd., a controlling subsidiary of Junyao Health. The company focuses on the research, development, production, and sales of probiotics, dedicated to providing comprehensive solutions. The company isOne of Asia's leading probiotic production bases, with a production base spanning 36,666 square meters and an annual capacity of 1200 tons of high-activity freeze-dried probiotic powder, Junyao Runying is one of the companies that drafted China's industry standard for "Lactic Acid Bacteria in Food Processing," demonstrating its deep expertise in the probiotics sector.20+ yearsestablished a strong industry reputation and trust.
The Juneyao Runying Research Institute is under the following:Basic Research Center, Technical Support Center, Process Research Center, Probiotic Application Center, Starter Culture Research CenterDedicated to developing safer, more stable probiotic products to meet market demand and drive industry innovation for sustainable, positive growth.
Dr. Hong Weilian will deliver a keynote presentation at this exhibition—Next-Generation Probiotic AKKBG-001®: Evidence-Based Weight Management and Industrial Applications。
AKKBG-001®Isolated from healthy human intestines in Kashgar, Xinjiang. Produced via Junyao Runying's proprietary anaerobic fermentation process combined with high-fidelity inactivation technology, ensuring a highly pure bacterial powder free from contaminating strains. This strain demonstrates exceptional safety: whole-genome sequencing has confirmed the absence of antibiotic resistance and virulence genes, as well as common allergens.Weight management, energy metabolism, and gut barrier repairDelivers multi-dimensional benefits. Clinical trials demonstrate its superior ability to inhibit fat absorption and promote fat breakdown, while also boosting energy metabolism. It targets the repair of damaged gastrointestinal mucosa, restores gut microbiota balance, and reduces intestinal inflammation.
Preview the highlights of the speech:
(1) The Next-Gen "Top-Tier" Probiotic — Akkermansia muciniphila
(2) Scientific Evidence on the Weight Management Benefits of Akkermansia muciniphila
(3) Industrial Application Potential of Akkermansia muciniphila
At the same time, this exhibition brings together the core strength of the entire biomanufacturing industry chain, featuring leaders from top-tier enterprises, academic pioneers from leading universities, authoritative experts from national research institutes, and key representatives of global industry think tanks. An all-star lineup with unmatched prestige!
